Market Tracker

12/17 6:05pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.40
Data as of Dec 17
 +0.46 / +9.31%
Today’s Change
3.20
Today|||52-Week Range
10.64
+43.24%
Year-to-Date

Today’s Trading

Previous close4.94
Today’s open4.94
Day’s range4.94 - 5.44
Volume606,073
Average volume (3 months)523,347
Market cap$307.4M
Dividend yield--
Data as of 4:00pm ET, 12/17/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TKAITokai Pharmaceutical...+0.62+4.52%
IDRAIdera Pharmaceutical...+0.30+8.36%
CORTCorcept Therapeutics...+0.11+3.56%
VVUSVIVUS Inc+0.12+3.90%
Data as of 4:00pm ET, 12/17/2014

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts